Captrust Financial Advisors Trims Holdings in Nutrien Ltd. (NYSE:NTR)

Captrust Financial Advisors lessened its stake in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 2.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 706,735 shares of the company's stock after selling 14,588 shares during the period. Captrust Financial Advisors owned about 0.14% of Nutrien worth $31,626,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of NTR. Balyasny Asset Management L.P. increased its position in Nutrien by 93.4% during the 4th quarter. Balyasny Asset Management L.P. now owns 17,995 shares of the company's stock valued at $805,000 after purchasing an additional 8,690 shares during the period. Bayesian Capital Management LP bought a new position in shares of Nutrien during the fourth quarter valued at approximately $201,000. Bank of America Corp DE increased its holdings in Nutrien by 5.9% during the fourth quarter. Bank of America Corp DE now owns 2,685,886 shares of the company's stock valued at $120,193,000 after buying an additional 150,464 shares during the period. American Trust Investment Advisors LLC raised its stake in Nutrien by 33.0% in the fourth quarter. American Trust Investment Advisors LLC now owns 14,860 shares of the company's stock worth $665,000 after buying an additional 3,690 shares in the last quarter. Finally, Aptus Capital Advisors LLC bought a new position in Nutrien in the fourth quarter worth approximately $511,000. Institutional investors own 63.10% of the company's stock.

Nutrien Stock Performance

Shares of NTR traded up $0.84 during mid-day trading on Friday, reaching $55.59. The company had a trading volume of 1,998,847 shares, compared to its average volume of 2,128,878. The stock has a 50 day moving average of $51.97 and a two-hundred day moving average of $49.96. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $27.14 billion, a P/E ratio of 40.58, a PEG ratio of 1.19 and a beta of 0.79. Nutrien Ltd. has a 52-week low of $43.70 and a 52-week high of $60.87.

Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.35 by ($0.24). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The firm had revenue of $4.67 billion for the quarter, compared to analyst estimates of $5.16 billion. During the same period in the previous year, the business earned $0.46 EPS. Nutrien's revenue for the quarter was down 5.4% compared to the same quarter last year. On average, analysts expect that Nutrien Ltd. will post 3.72 earnings per share for the current year.

Nutrien Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 18th. Investors of record on Monday, June 30th will be issued a $0.545 dividend. The ex-dividend date is Monday, June 30th. This represents a $2.18 dividend on an annualized basis and a yield of 3.92%. Nutrien's payout ratio is 203.74%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on NTR shares. UBS Group boosted their price target on Nutrien from $52.00 to $56.00 and gave the stock a "neutral" rating in a research report on Thursday. Oppenheimer reduced their price objective on shares of Nutrien from $60.00 to $58.00 and set an "outperform" rating for the company in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. upgraded shares of Nutrien from an "underweight" rating to a "neutral" rating and raised their target price for the company from $40.00 to $50.00 in a research note on Monday, January 13th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $60.00 price target on shares of Nutrien in a research report on Monday, February 24th. Finally, The Goldman Sachs Group increased their price objective on Nutrien from $53.00 to $59.00 and gave the company a "sell" rating in a report on Friday. Two analysts have rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $59.93.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.